Biomarkers in Oncology

Biomarkers play a significant role in oncology that is used in clinical research for risk valuation, differential diagnosis, determination of the nature of tumors, for recognition purposes, to determine the prognosis and dose-response of the drug to the cure. The procedure indicative of the presence of cancer in the body is carried out by means of tools known as cancer biomarkers. There are different types of cancer in which biomarkers have their presentation, such as lung, melanoma, breast, colorectal, pancreas and many more. Biochemically, cancer biomarkers can be DNA, RNA, proteins, peptides, hormones, metabolites and even biological procedures such as apoptosis, angiogenesis or proliferation. Around three key types of cancer biomarkers depending on their clinical use: prognostic, predictive and pharmacodynamics markers.

 

  • Diagnosis and treatment
  • Lung Cancer
  • Cervical Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Prostate cancer
  • Testicular Cancer
  • Cancer Biomarkers in clinical research

Related Conference of Biomarkers in Oncology

January 28-29, 2019

10th Asia Pacific Congress on Polymer Science and Engineering

Courtyard by Marriott Seoul Times Square,Seoul, South Korea
February 18-20, 2019

16th Annual Congress on

Materials Research and Technology

Amsterdam, Netherlands
March 11-12, 2019

5th Annual Conference on Biomaterials

Nice, France
April 24-25, 2019

World Congress on Nanomaterials and Nanotechnology

Budapest | Hungary
May 27-28,2019 |

21st World Congress on Materials Science and Engineering

Four Points by Sheraton | Taipei,Taiwan
July 22-23, 2019

35th World Congress on Materials Science and Nanotechnology

Mercure Albert Park, Melbourne, Australia
August 19-20, 2019,

23rd International Conference on Advanced Materials & Nanotechnology

Radisson Hotel Narita, Tokyo, Japan

Biomarkers in Oncology Conference Speakers